Islet Sciences Announces Receipt of $2.1 Million in Grant Support of ... ( NEW YORK April 9 2012 /- Islet Scienc...)

Islet Sciences Announces Receipt of $2.1 Million in Grant Support of Technology

Date:4/9/2012

NEW YORK, April 9, 2012 /PRNewswire/ -- Islet Sciences, Inc., (OTCBB: ISLT) a biotechnology company engaged in the research, development and commercialization of patented technologies in the field of transplantation therapy for patients with diabetes, announced today that its wholly-owned subsidiary DiaKine Therapeutics, Inc. has received grant support totaling approximately $2.1 million. The grants include $1,831,250 from the National Institutes of Health (NIH) and $250,000 from the Iacocca Foundation.

"Clearly, the receipt of these grants will help our company execute our ongoing initiatives and is a vote of confidence from such well known organizations," said Dr. Jerry L. Nadler, Islet Sciences Director. "As we continue to make progress with our diabetes therapies this grant support is a testament to the value of our therapies which represents such a large market opportunity for Islet Sciences."

"We are pleased to announce these grants which obviously strengthens our value proposition," said John Steel, Chairman and CEO of Islet Sciences. "Our approach to the treatment of diabetes in addition to other inflammatory diseases and autoimmune disorders are what attracted these esteemed institutions as we capitalize on the growing opportunities in this field. We look forward to announcing additional milestones in the coming months."

About Islet Sciences, Inc.

Islet Sciences is a development-stage biotechnology company with patented technologies focused on transplantation therapy for people with insulin-dependent diabetes. The Company's transplantation technology includes methods for the culturing, isolation, maturation, and immunoprotection (microencapsulation) of islet cells. The Company's mission includes the introduction of commercial products with applications to cell-based replacement therapy in the healthcare marketplace.

Forward-Looking Statements

This press release contains forward-looking statem
'/>"/>

SOURCE Islet Sciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related biology technology :

1. Islet Sciences Announces DiaKine Therapeutics Novel Diabetes, Atherosclerosis Drugs Receives European Patent Protection
2. Islet Sciences, Inc. Selects NeoStems Manufacturing Subsidiary Progenitor Cell Therapy for Product Manufacturing
3. Beta-Pro Donates Human Islet Cells to Diabetes Researcher
4. Pigs to Be Genotyped to Improve Selection and Breeding for Pancreatic Islet Cell Research
5. BioLife Solutions HypoThermosol(R) Adopted by MicroIslet for Processing Pancreatic Islet Cells to Treat Diabetes
6. Human Pheromone Sciences Voluntarily Files With SEC for Termination of Registration
7. Regado Biosciences, Inc. to Present at Needham & Companys 11th Annual Healthcare Conference in New York, NY
8. Frost & Sullivan Announces Cutting Edge Life Sciences Research on the Horizon
9. Nautilus Neurosciences, Inc. Announces a New Approval for CAMBIA® for the Acute Treatment of Migraine
10. Shire to Acquire FerroKin BioSciences, Inc., and its Phase 2 Iron Chelator Treatment
11. Neurocrine Biosciences to Present at The 24th Annual Roth Conference

Post Your Comments:

(Date:6/18/2013)... June 18, 2013 China Cord Blood Corporation ... China,s leading provider of cord blood collection, laboratory testing, ... today announced its preliminary unaudited financial results for the ... ended March 31, 2013. Fourth Quarter ... fourth quarter of fiscal 2013 increased by 33.3% to ...

(Date:6/18/2013)... PA (PRWEB) June 18, 2013 Demanding ... Ball Lenses engineered of synthetic Sapphire and Glass Ball ... sizes from Swiss Jewel Company , of Philadelphia ... by expanding and collimating the light beams without the ... optical clarity and natural durability (9 mohs) make it ...

(Date:6/18/2013)... RegeneCure announced today the start of a ... (GBR) Dental Membrane as a bone stimulating aid for patients ... patients have a tooth replaced with a dental implant is ... Consequently there is often a need to support the implant ... bone substitute material, in turn, needs to be held in ...

(Date:6/18/2013)... , June 18, 2013 AMRI (NASDAQ: ... Burlington, Mass. , site has ... Enforcement Administration (DEA) registration to handle Schedule 2 ... DEA,s acknowledgement of Burlington,s ... and documentation. (Logo: http://photos.prnewswire.com/prnh/20120229/NY61160LOGO ) ...

[0] China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 [0] Swiss Jewel Introduces the Crown Jewels of Fiber-Optic Connectors [0] RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants [0] AMRI Burlington Receives DEA Approval to Handle Controlled Substances

... 31 Savient,Pharmaceuticals, Inc. (Nasdaq: SVNT ) today ... and Drug Administration (FDA) seeking approval to,market pegloticase in ... review. Savient,s filing includes data from both the six-month,placebo ... from the Open,Label Extension (OLE) study. The data set ...

... 31 /Xinhua-PRNewswire/ -- Sundia MediTech,Company, a Shanghai-based drug ... this year,s Deloitte Technology,Fast 50 China award, and ... 50 China Program was announced today in Shenzhen, ... 50 Program started in 1995 in San Jose. ...

... than a dozen employers in health care, employment continued to increase in ... like no one was searching for those new jobs. , ... Seattle, ... care field, with an average of 30,000 jobs created each month. Even ...

Cached Biology Technology:Savient Submits Biologics License Application (BLA) for pegloticase 2 Savient Submits Biologics License Application (BLA) for pegloticase 3 Savient Submits Biologics License Application (BLA) for pegloticase 4 Sundia MediTech Ranked #16 in Deloitte Technology Fast 50 China 2 The MedZilla Report: September 2008 Employment Outlook for Biotech/Pharma/Health 2 The MedZilla Report: September 2008 Employment Outlook for Biotech/Pharma/Health 3

Savient Submits Biologics License Application (BLA) for pegloticase Sundia MediTech Ranked #16 in Deloitte Technology Fast 50 China The MedZilla Report: September 2008 Employment Outlook for Biotech/Pharma/Health

(Date:6/18/2013)... It is estimated that between 5% and 10% of ... is to say that these tumours are attributable to ... BRCA1 or BRCA2. In patients with these mutations, PARP ... encouraging results that make them a new option for ... the latest studies indicate that a fraction of these ...

(Date:6/18/2013)... LA, London (18 June 2013). A team of internationally ... by Dr Sarah Ellis from the University of Lincoln, ... Clinic, Wisconsin, U.S.A. were invited by the International Society ... Feline Practitioners (AAFP) to compile guidelines for veterinarians, owners ... the environmental needs of the domestic cat. The new ...

(Date:6/17/2013)... MA Women in the U.S. exposed to high levels ... likely to have a child with autism as women who ... study from Harvard School of Public Health (HSPH). It is ... and air pollution across the U.S. , "Our findings raise ... the women in our study lived in areas where risk ...

Breaking Biology News(10 mins):An article in 'Cell' reveals a new resistance mechanism to chemotherapy in breast and ovarian cancer 2 Feline behavior experts release guidelines to improve the welfare of cats 2 Exposure to high pollution levels during pregnancy may increase risk of having child with autism 2

[0] An article in 'Cell' reveals a new resistance mechanism to chemotherapy in breast and ovarian cancer [0] Feline behavior experts release guidelines to improve the welfare of cats [0] Exposure to high pollution levels during pregnancy may increase risk of having child with autism

... April 14, 2011 -- The number of couples struggling with ... assisted reproductive technologies, like in vitro fertilization (IVF), to get ... increase the risk of multiple pregnancies (i.e., twins or triplets), ... Twins and triplets are likely to be born prematurely, ...

... 2011 Ceelox, Inc. (OTCBB: CELO) announced today that ... to cloud applications using biometrics. Ceelox ID Online® utilizes ... an Internet server-based biometric software application. This enables users ... credentials, i.e. user name and password, compromised or stolen ...

... The following highlights summarize research papers that have been ... 1. Little Ice Age resulted from more than just ... measure of the amount of light the Sun puts out, ... especially when TSI is notably higher or lower than its ...

Cached Biology News:New study finds stronger regulations of in vitro fertilization may save lives 2 Ceelox Provides Biometric Identity Access to Cloud Applications 2 Ceelox Provides Biometric Identity Access to Cloud Applications 3 AGU journal highlights -- April 13, 2011 2 AGU journal highlights -- April 13, 2011 3 AGU journal highlights -- April 13, 2011 4 AGU journal highlights -- April 13, 2011 5 AGU journal highlights -- April 13, 2011 6 AGU journal highlights -- April 13, 2011 7

New study finds stronger regulations of in vitro fertilization may save lives Ceelox Provides Biometric Identity Access to Cloud Applications AGU journal highlights -- April 13, 2011

...

BD BioCoat Collagen IV 35 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of mouse collagen type IV....

... are designed for sequencing inserts cloned into ... or T3 RNA polymerase promoters, or lambda ... at a concentration of 0.1 µg/µl in ... DNA sequencing reactions using SequiTherm™ EXCEL™ II ...

BD BioCoat Matrigel Matrix 35 mm Culture Dishes Coating : BD MatrigelTM Basement Membrane Matrix ,Surface : ECM/attachment factors ,Surface area : 9.6 cm2 ,Dim nominal : 35 mm x 10 mm ,Vo...

Biology Products:

Eppendorf Thermomixer R from Eppendorf North America BD BioCoat Collagen IV 35 mm Culture Dishes from BD Biosciences - Discovery Labware Lambda GT11 Forward DNA Sequencing Primer from EPICENTRE Biotechnologies BD BioCoat Matrigel Matrix 35 mm Culture Dishes from BD Biosciences - Discovery Labware